Adults may be concerned about their children's vaccinations, but are they concerned with their own? New data from a US survey suggests that adult vaccination levels may need a boost.

HIV treatment can help patients manage their condition if it is started early. However, not everyone seeks out treatment early enough.

By 2015, HIV patients are expected to be surviving to and past 50 years old. Therefore, these patients may need to be closely monitored for conditions tied to older age, such as heart disease.

Hepatitis C patients may soon have a much more effective and simple treatment. One recent study showed that combining two new medications was safe and reduced the amount of active virus in patients.

Advances in drug therapy for HIV are allowing HIV patients to live fuller and longer lives. It's possible that the average life expectancy of an HIV-positive person with treatment is approaching the life expectancy of uninfected people.

Structural heart disease is very common in HIV patients. It's possible that the conditions are directly related.

Patients with the hepatitis C virus (HCV), which primarily affects the liver, face a higher chance of getting diabetes. Antiviral HCV medication, however, may improve diabetes outcomes.

If there was a vaccine that could possibly prevent cancer, everyone would get it — right? The answer is more complicated than that, as a new study focusing on HPV vaccination showed.

Sometimes it's easy to forget how common many diseases were before vaccines for them were introduced. When the disease is not around, people may not notice as much.

New advancements in HIV treatment have allowed many people to live with a very small amount of the virus in their bodies. But what are the pros and cons?